[Ticlopidine use in Spain: a pharmacy-based drug utilization study].
In 1997 a program was set up to improve the use of ticlopidine. In the present study we assess whether this objective was achieved. We carried out a pharmacy-based cross-sectional study. Out of 346 patients interviewed, 56% presented an off-label indication for ticlopidine. In 23% of patients the daily dose used was lower or higher than the recommended. Only 28% patients had the fortnightly blood monitoring performed at the time of interview. The use of ticlopidine in Spain is not consistent with the summary of product characteristics and the program set up to improve it did not achieve a satisfactory result.